Assessing Physician and Patient Acceptance of Infliximab Biosimilars in Rheumatoid Arthritis, Ankylosing Spondyloarthritis and Psoriatic Arthritis Across Germany
Patient Preference and Adherence- New Zealand
doi 10.2147/ppa.s129333
Full Text
Abstract
Available in
Date
March 1, 2017
Authors
Publisher
Informa UK Limited